Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3

National Medical Journal of China

Volumn 89, Issue 42, 2009, Pages 2997-3001

  Ji, Wen Juan ^a   Qu, Qiang ^a   Jin, Ye ^a   Zhao, Lei ^a   He, Xiao Dong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Apoptosis; Cysteine endopeptidases; Hepatocyte; Ursodeoxycholic acid

Indexed keywords

BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; CASPASE 3; PROTEIN BAX; URSODEOXYCHOLIC ACID;

ANIMAL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; FEMALE; LIVER CELL; MESENCHYMAL STEM CELL; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BONE MARROW CELLS; CASPASE 3; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HEPATOCYTES; MESENCHYMAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; URSODEOXYCHOLIC ACID;

EID: 84871406185     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.42.014     Document Type: Article

References (14)

1. Ikegami T, Matsuzaki Y. Ursodeoxycholic acid: mechanism of action and novel clinical applications. Hepatol Res, 2008, 38: 123-131.
2. 2005, 43: 713-715.
3. 2006, 23: 1316-1318.
4. 2009, 6: 151-153.
5. Sold S, Aranha MM, Steer CJ, et al. Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid. Curr Issues Mol Biol, 2007, 9: 123-138.
6. Haupt S, Berger M, Goldberg Z, et al. Apoptosis-the p53 network. Cell Sci, 2003, 15: 4077-4085.
7. Sold S, Ma X, Castro RE, et al. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor betal-induced apoptosis of rat hepatocytes. Biol Chem, 2003, 278: 48831-48838.
8. Azzaroli F, Mehal W, Soroka CJ, et al. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology, 2002, 36: 49-54.
9. Im E, Akare S, Powell A, et al. Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling. Nutr Cancer, 2005, 51: 110-116.
10. Schoemaker MH, de la Rosa LC, Buist-Homan M, et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology, 2004, 39: 1563-1573.
11. Amaral JD, Castro RE, Sold S, et al. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J Biol Chem, 2007, 282: 34250-34259.
12. Epand RF, Martinou JC, Montessuit S, et al. Direct evidence for membrane pore formation by the apoptotic protein Bax. Biochem Biophys Res Commun, 2002, 298: 744-749.
13. Castro RE, Amaral JD, Sola' S, et al. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes. Am J Physiol Gastrointest Liver Physiol, 2007, 293: G327-G334.
14. Sola' S, Joana D, Amaral JD, et al. Nuclear translocation of UDCA by the flucocorticoid receptor is required to reduce TGF-_1-induced apoptosis in rat hepatocytes. Hepatology, 2005, 42: 925-934.